POLICY AND REGULATIONINSURANCE AND ACCESS
The GLP-1 medication market is seeing significant changes, including FDA approval of oral weight loss drugs and expanded Medicare coverage starting in July 2024. These shifts could make weight loss medications more accessible to patients.
Source: Beckershospitalreview